NewAmsterdam Pharma Co NV (FRA:KH6) Scaled Net Operating Assets : -0.10 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NewAmsterdam Pharma Co NV's operating assets for the quarter that ended in Dec. 2023 was €6.10 Mil. NewAmsterdam Pharma Co NV's operating liabilities for the quarter that ended in Dec. 2023 was €53.78 Mil. NewAmsterdam Pharma Co NV's Total Assets for the quarter that ended in Jun. 2023 was €472.54 Mil. Therefore, NewAmsterdam Pharma Co NV's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -0.10.

NewAmsterdam Pharma Co NV Scaled Net Operating Assets Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Scaled Net Operating Assets Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.02

-0.34

-0.59

-0.11

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial			-	1.57	-0.17	0.09	-0.10

Competitive Comparison of NewAmsterdam Pharma Co NV's Scaled Net Operating Assets

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's Scaled Net Operating Assets falls into.

NewAmsterdam Pharma Co NV Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NewAmsterdam Pharma Co NV's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(6.095	-	53.777)	/	451.701
=	-0.11

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	318.288	-	312.193
=	6.095

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	53.832	-	0	-	0.055
=	53.777

NewAmsterdam Pharma Co NV's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(6.095	-	53.777)	/	472.542
=	-0.10

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	318.288	-	312.193
=	6.095

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	53.832	-	0	-	0.055
=	53.777

NewAmsterdam Pharma Co NV Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

NAMS:USA KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines